Skip to main content
Caplight Logo









Mesentech Inc.

Mesentech Inc.

Private
VancouverHealthcare & Life Scienceshttps://mesentech.com

Last Round

VC Round

Oct 4, 2023

Company Overview

Mesentech Inc. operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a VC Round in October 2023.

Mesentech Inc. is a biotechnology company that develops bone-targeted drug-conjugate therapies for the treatment of musculoskeletal disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Mesentech Inc. Comparables

Compare Mesentech Inc. with similar companies based on industry and business-model similarity.

Mesentech Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Atlanthera
87%
Taithera, Inc.
85%
Skeletalis Bio
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Mesentech Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 4, 2023
VC RoundNov 10, 2020
VC RoundJun 22, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Mesentech Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 33% MoM.

  • Jan 26, 2025

    Monthly visitors increased 873% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Mesentech Inc. Filings

Explore SEC and related filing metadata, where available.

Mesentech Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Mesentech Inc.'s valuation, stock price, and market status.

Is Mesentech Inc. a public or private company?

Mesentech Inc. is a private company.

What is the current stock price of Mesentech Inc.?

Mesentech Inc. is a private company, so its shares have no public market price. Caplight tracks Mesentech Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Mesentech Inc. worth (valuation)?

Valuation information for Mesentech Inc. is not publicly available.

Can I buy Mesentech Inc. stock?

Mesentech Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Mesentech Inc.'s last funding round?

Mesentech Inc.'s most recent funding round was VC Round on October 4, 2023.

Who are the main investors in Mesentech Inc.?

Key investors in Mesentech Inc. include Consortium Québécois sur la découverte du médicament.

Will Mesentech Inc. IPO soon?

No public IPO plans have been announced for Mesentech Inc..

How can I track Mesentech Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Mesentech Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersVancouver
Employee Range9
Year Founded2018
Last FundingOct 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?